For media inquiries, please contact press@allazohealth.com
Case study demonstrates how personalized email components powered by AI can improve patient experience and boost medication adherence NEW YORK – January 28, 2025 –AllazoHealth, the pioneer in driving therapy initiation, adherence, and health outcomes…
Read MoreCase study shows boost in therapy initiation and adherence when AI-enabled personalized communications are deployed NEW YORK – October 31, 2024 – AllazoHealth, the pioneer in driving therapy initiation, adherence, and health outcomes with artificial intelligence (AI)-powered personalization,…
These key additions will guide AllazoHealth as it scales product development to support pharma companies with AI-powered personalization technology NEW YORK, NY – October 15, 2024 – AllazoHealth, the pioneer in driving therapy initiation, adherence,…
AI-Enabled Dynamic Modular Content is a first-of-its-kind solution that empowers pharmaceutical companies to customize an individual patient’s digital engagement and improve health outcomes NEW YORK, NY – September 24, 2024 – AllazoHealth, the pioneer in driving…
AllazoHealth continues to lead in advancing the use of artificial intelligence in healthcare. Building on our success in medication adherence, we have expanded our implementation of AI to include therapy initiation.
Read moreAllazoHealth, a company that uses artificial intelligence to help pharmaceuticals, payers, and pharmacies improve medication adherence and quality outcomes, announced today that pharmaceutical industry veteran Mark Degatano will be joining the company’s Advisory Board.
Read moreNew York, NY – AllazoHealth announced today that William Grambley will take on the position of Chief Executive Officer after serving more than two years as Chief Operating Officer at the fast-growing healthcare AI company.…
Read moreIn the Fall 2019 edition of BioSupply Trends Quarterly, AllazoHealth CEO William Grambley shares how artificial intelligence (AI) will change the healthcare landscape. “There are so many places where AI is impacting people’s lives that…
Read moreNEW YORK, NY and FORT MILL, SC (March 4, 2019) – Lash Group, a patient support services company and a part of AmerisourceBergen, and AllazoHealth, an artificial intelligence (AI) and predictive analytics company focused on ensuring optimal patient outcomes, today announced
Read moreAllazoHealth has co-published a randomized controlled study with Blue Cross Blue Shield of North Carolina.
Read moreNew York, NY – AllazoHealth, the AI and predictive analytics company focused on predicting and changing patient behaviors through precision engagement, announced today that Steve Cohan will be joining the company’s Advisory Board. Prior to joining…
Read moreNew York, NY – AllazoHealth, the healthcare technology company using Artificial Intelligence to predict and change patient behavior through precision engagement, announced today that Bill Grambley has joined the company as Chief Operating Officer. Prior…
Read moreIn the September 2018 issue of MM&M, Davin Cho, VP of commercial strategy at AllazoHealth, outlines the future of medication adherence in the feature, “Adherence Intelligence is the New AI.” While medication non-adherence isn’t a…
Read moreNew York, NY – AllazoHealth, the industry leader in optimizing medication adherence programs through artificial intelligence (AI), today announced that its AllazoEngine™ platform was named the winner of the Data Analytics & Business Intelligence category…
Read moreDownload our infographic to learn how manufacturers can drive patient behaviors for better therapy initiation, adherence, and health outcomes using AI-powered personalization at the individual level.
Download InfographicExplore our comprehensive media kit that’s been curated to provide the AllazoHealth experience. Delve into a diverse array of content such as logos, headshots, content, and the latest news that showcases the depth and breadth of our offerings.
Download Media Kit